Table 2 Demographic and clinical characteristics of the Study Participants after discharge

Sex

 Male

32 (78.0%)

45 (75%)

24 (80.0%)

14 (77.8%)

7 (58.3%)

 Female

9 (22.0%)

15 (25%)

6 (20.0%)

4 (22.2%)

5 (41.7%)

 Age (years)

45.00 (38.50, 51.50)

42.00 (36.00,52.00)

43.50 (36.75,53.25)

38.50 (32.75,53.25)

44.00 (38.25,53.75)

 BMI

26.15 (24.33,27.52)

26.20 (24.28,28.33)

26.02 (24.35,27.73)

26.98 (24.88,28.52)

26.00 (23.00,26.00)

 AO

19 (46.3%)

43 (71.7%)^a

19 (63.3%)

15 (83.3%)^a

9 (75.0%)

 WTI

265.60 (156.07,657.76)

420.34 (213.60,1048.48)^a

357.55 (172.27,720.78)

515.32 (270.39,1058.11)

867.48 (311.09,1349.43)

 Smoking

23 (56.1%)

38 (63.3%)

21 (70.0%)

10 (55.6%)

7 (58.3%)

 Alcohol

27 (65.8%)

39 (65.0%)

22 (73.3%)

10 (55.6%)

7 (58.3%)

 Lipid-lowering medications

12 (29.3%)

30 (50.0%)

12 (40.0%)

8 (44.4%)

10 (83.3%)^{a b c}

Comorbidities (n,%)

 Diabetes

5 (12.2%)

30 (50.0%)^a

12 (40.0%)^a

9 (50.0%)^a

9 (75.0%)^{a b}

 PPDM-A

4 (9.8%)

18 (30.0%)^a

6 (20.0%)

7 (38.9%)^a

5 (41.7%)^a

 Hypertension

12 (29.3%)

15 (15.00%)

8 (26.7%)

3 (16.7%)

4 (33.3%)

 New onset of Hypertension

5 (12.2%)

7 (11.7%)

3 (10.0%)

2 (11.1%)

2 (16.7%)

 Fatty liver

14 (34.1%)

28 (46.7%)

9 (30.0%)

12 (66.7%)^{a b}

7 (58.3%)

 New onset of Fatty liver

3 (7.3%)

6 (10.0%)

1 (3.3%)

4 (22.2%)

1 (8.3%)

 Mets

5 (12.2%)

29 (48.3%)^a

10 (33.3%)^a

10 (55.6%)^a

9 (75.0%)^{a b}

 WBC (109/L)

6.28 ± 1.46

7.01 ± 3.59

6.16 (5.15,8.18)

6.96 (5.36,8.36)

5.89 (5.48,6.96)

 CRP (mg/L)

1.14 (0.47,2.36)

1.15 (0.53,2.53)

1.14 (0.43,2.38)

1.67 (0.92,3.92)

1.00 (0.32,1.60)

 Total bilirubin (umol/L)

13.20 (7.60,13.20)

11.80 (9.30,16.15)

12.10 (9.60,17.05)

12.60 (10.55,17.47)

9.65 (8.92,13.20)

 Direct bilirubin (umol/L)

3.30 (2.75,4.00)

3.00 (2.40,3.68)

3.15 (2.37,4.15)

3.05 (2.65,3.40)

2.45 (1.75,2.97)

 Indirect bilirubin (umol/L)

9.85 (6.03,13.25)

8.80 (6.73,11.25)

8.80 (6.65,11.47)

9.55 (7.72,13.85)

7.75 (6.07,10.25)

 ALT (U/L)

28.20 (18.35,48.00)

28.85 (20.00, 40.75)

29.85 (19.25,82.80)

30.00 (19.25,45.00)

27.50 (12.50,35.75)

 AST (U/L)

25.20 (19.35,31.00)

22.10 (18.85,31.43)

22.40 (18.77,33.30)

22.80 (19.55,28.87)

20.50 (17.75,26.67)

 GGT (U/L)

42.10 (24.55,83.25)

40.85 (22.95,68.37)

55.45 (26.42,90.37)

37.25 (19.32,52.47)

37.10 (21.15,67.25)

 FPG (mmol/L)

6.25 (5.31,8.91)

6.80 (5.62,10.00)

6.44 (5.75,7.98)

6.25 (5.34,12.14)

10.14 (7.40,12.74)^{a b}

 2hPG (mmol/L)

8.36 (6.27,14.26)

10.89 (7.41,14.97)

9.79 (7.01,11.71)

8.37 (6.39,16.95)

14.85 (12.31,18.46)^{a b}

 HbA1c (%)

5.50 (5.25,7.00)

6.00 (5.40,7.80)^a

5.75 (5.40,7.12)

6.00 (5.15,9.30)

7.90 (6.75,9.27)^{a b}

 BUN (mmol/L)

5.38 (4.49,6.22)

5.58 (4.76,6.59)

5.63 (4.98,6.65)

5.40 (4.20,6.62)

5.54 (4.41,6.27)

 UA (umol/L)

333.60 (281.60,428.50)

346.15 (288.80,405.82)

369.50 (298.70,484.20)

349.55 (306.05,405.67)

311.15 (287.35,361.00)

 Creatinine (umol/L)

68.10 (59.00, 79.10)

67.35 (53.70,79.95)

68.85 (55.60,87.55)

58.80 (50.07,71.30)

63.70 (33.65,84.00)

 TG (mmol/L)

3.00 (1.76,7.80)

4.50 (2.64,9.58)

3.94 (1.94,8.01)

5.02 (3.10,10.19)

8.62 (3.70,14.91)

 TC (mmol/L)

5.20 (4.51,5.75)

5.58 (4.42,6.49)

5.38 (4.38,5.99)

5.74 (4.75,6.60)

5.88 (4.16,7.87)

 HDL (mmol/L)

1.04 (0.91,1.15)

0.96 (0.85,1.16)

0.98 (0.86,1.22)

0.94 (0.82,1.11)

0.91 (0.84,1.01)

 LDL (mmol/L)

2.3 (1.87,2.96)

2.04 (1.53,2.68)

2.31 (1.66,3.11)

2.34 (1.68,2.80)

1.53 (1.36, 1.76)